ID   FREM1_MOUSE             Reviewed;        2191 AA.
AC   Q684R7; Q5H8C2; Q5M7B3; Q8C732;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   03-AUG-2022, entry version 132.
DE   RecName: Full=FRAS1-related extracellular matrix protein 1;
DE   AltName: Full=Protein QBRICK;
DE   Flags: Precursor;
GN   Name=Frem1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, DISEASE, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=C57BL/6J;
RX   PubMed=15345741; DOI=10.1073/pnas.0402760101;
RA   Smyth I., Du X., Taylor M.S., Justice M.J., Beutler B., Jackson I.J.;
RT   "The extracellular matrix gene Frem1 is essential for the normal adhesion
RT   of the embryonic epidermis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:13560-13565(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF ASP-207.
RX   PubMed=15878328; DOI=10.1016/j.yexcr.2005.01.020;
RA   Kiyozumi D., Osada A., Sugimoto N., Weber C.N., Ono Y., Imai T., Okada A.,
RA   Sekiguchi K.;
RT   "Identification of a novel cell-adhesive protein spatiotemporally expressed
RT   in the basement membrane of mouse developing hair follicle.";
RL   Exp. Cell Res. 306:9-23(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1096-2191 (ISOFORM 3).
RC   STRAIN=C57BL/6J; TISSUE=Kidney;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1737-2191.
RC   TISSUE=Limb;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Extracellular matrix protein that plays a role in epidermal
CC       differentiation and is required for epidermal adhesion during embryonic
CC       development. {ECO:0000269|PubMed:15345741}.
CC   -!- SUBUNIT: Interacts with FREM2. {ECO:0000250|UniProtKB:Q5SZK8}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix, basement membrane {ECO:0000269|PubMed:15878328}. Note=Localizes
CC       at the basement membrane zone of embryonic epidermis and hair
CC       follicles. {ECO:0000269|PubMed:15878328}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q684R7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q684R7-2; Sequence=VSP_015032;
CC       Name=3;
CC         IsoId=Q684R7-3; Sequence=VSP_015033, VSP_015034;
CC   -!- TISSUE SPECIFICITY: Expressed in epidermis and hair follicles.
CC       Expressed in many developing epidermal appendages, including the
CC       whisker and sensory vibrissae, cranial and trunk hair follicles,
CC       meibomian glands, teeth, footpads, eyelash primordia and invaginating
CC       mammary glands. Limb expression localizes to sheets of dermal cells on
CC       the apical and basal surfaces of the digits but, unlike FRAS1, is
CC       excluded from the apical ectodermal ridge. Usually expressed at higher
CC       level in dermal cells underlying the differentiating epithelial
CC       components, especially underlying the epidermis of the head, limbs, and
CC       eyelids. Expression in the eyelid dermis is apparent as early as 13
CC       dpc. Postnatal expression in the skin is limited to the dermal
CC       papillae. In the kidney, it is expressed from 12.5 dpc in the
CC       mesenchyme surrounding the branching ureteric tree, with a strong
CC       expression in the more proximal regions of these tubules rather than at
CC       the proliferating and branching ends of the ureteric buds. In hair
CC       follicle, it is selectively expressed in the vibrissal hair primordia
CC       during development. Preferentially expressed in the whisker pad
CC       epithelia of 12.5 dpc embryos, in both the epithelial and mesenchymal
CC       cells of developing hair follicles. In the early stages of hair
CC       follicle development (i.e. stages 0-1), it is expressed in both hair
CC       placodes and dermal condensations. In stage 2, it is detected in dermal
CC       condensations and adjacent epithelia, but not in the upper region of
CC       the hair follicles. Expressed at the tip of developing hair follicles
CC       in the later stages (i.e. stages 3-5). {ECO:0000269|PubMed:15345741,
CC       ECO:0000269|PubMed:15878328}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the embryos of all stages examined
CC       and in some adult tissues including eye, kidney, ovary, urinary bladder
CC       and testes; however, the overall expression levels in adult tissues are
CC       relatively low compared with those in embryonic tissues.
CC   -!- DOMAIN: The Calx-beta domain binds calcium with high affinity and
CC       undergo a major conformational shift upon binding. {ECO:0000250}.
CC   -!- DISEASE: Note=Defects in Frem1 are the cause of head blebs (heb) which
CC       is a spontaneous mutation that is characterized by absent or malformed
CC       eyes, which are often open at birth. Cryptophthalmos is noted in all
CC       heb homozygous animals, as is occasional hindlimb polydactyly.
CC       {ECO:0000269|PubMed:15345741}.
CC   -!- MISCELLANEOUS: Was termed QBRICK because it contains 12 repeats: 'Q'
CC       stands for queen and is taken from the queen being the 12th in a suit
CC       of playing card, and 'BRICK' stands for the repeating unit.
CC   -!- MISCELLANEOUS: Frem1 also corresponds to a N-ethyl-N-nitrosourea-
CC       induced allele called 'bat'. Homozygous bat mice display similar
CC       phenotype than heb mice.
CC   -!- SIMILARITY: Belongs to the FRAS1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH88732.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAC35069.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ616838; CAE83577.1; -; mRNA.
DR   EMBL; AB160986; BAD89014.1; -; mRNA.
DR   EMBL; AK052629; BAC35069.1; ALT_INIT; mRNA.
DR   EMBL; BC088732; AAH88732.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS38791.1; -. [Q684R7-1]
DR   CCDS; CCDS57281.1; -. [Q684R7-2]
DR   RefSeq; NP_001185740.1; NM_001198811.1. [Q684R7-2]
DR   RefSeq; NP_808531.2; NM_177863.4. [Q684R7-1]
DR   RefSeq; XP_006538076.1; XM_006538013.3. [Q684R7-2]
DR   RefSeq; XP_006538077.1; XM_006538014.2. [Q684R7-2]
DR   RefSeq; XP_006538078.1; XM_006538015.1. [Q684R7-2]
DR   RefSeq; XP_011248357.1; XM_011250055.2. [Q684R7-2]
DR   AlphaFoldDB; Q684R7; -.
DR   DIP; DIP-61243N; -.
DR   IntAct; Q684R7; 2.
DR   STRING; 10090.ENSMUSP00000071627; -.
DR   GlyGen; Q684R7; 6 sites.
DR   iPTMnet; Q684R7; -.
DR   PhosphoSitePlus; Q684R7; -.
DR   MaxQB; Q684R7; -.
DR   PaxDb; Q684R7; -.
DR   PRIDE; Q684R7; -.
DR   ProteomicsDB; 266856; -. [Q684R7-1]
DR   ProteomicsDB; 266857; -. [Q684R7-2]
DR   ProteomicsDB; 266858; -. [Q684R7-3]
DR   Antibodypedia; 42751; 97 antibodies from 23 providers.
DR   DNASU; 329872; -.
DR   Ensembl; ENSMUST00000071708; ENSMUSP00000071627; ENSMUSG00000059049. [Q684R7-1]
DR   Ensembl; ENSMUST00000107230; ENSMUSP00000102849; ENSMUSG00000059049. [Q684R7-2]
DR   GeneID; 329872; -.
DR   KEGG; mmu:329872; -.
DR   UCSC; uc008tkm.2; mouse. [Q684R7-1]
DR   CTD; 158326; -.
DR   MGI; MGI:2670972; Frem1.
DR   VEuPathDB; HostDB:ENSMUSG00000059049; -.
DR   eggNOG; KOG3597; Eukaryota.
DR   GeneTree; ENSGT00940000156990; -.
DR   InParanoid; Q684R7; -.
DR   OMA; MVYVTDG; -.
DR   OrthoDB; 13258at2759; -.
DR   PhylomeDB; Q684R7; -.
DR   TreeFam; TF316876; -.
DR   BioGRID-ORCS; 329872; 1 hit in 72 CRISPR screens.
DR   ChiTaRS; Frem1; mouse.
DR   PRO; PR:Q684R7; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; Q684R7; protein.
DR   Bgee; ENSMUSG00000059049; Expressed in renal medulla interstitium and 158 other tissues.
DR   ExpressionAtlas; Q684R7; baseline and differential.
DR   Genevisible; Q684R7; MM.
DR   GO; GO:0005604; C:basement membrane; IDA:BHF-UCL.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; IBA:GO_Central.
DR   GO; GO:0007154; P:cell communication; IEA:InterPro.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:MGI.
DR   GO; GO:0097094; P:craniofacial suture morphogenesis; ISS:UniProtKB.
DR   Gene3D; 2.60.40.2030; -; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR038081; CalX-like_sf.
DR   InterPro; IPR003644; Calx_beta.
DR   InterPro; IPR039005; CSPG_rpt.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR045658; FRAS1-rel_N.
DR   InterPro; IPR032825; FREM1.
DR   PANTHER; PTHR45739:SF7; PTHR45739:SF7; 1.
DR   Pfam; PF03160; Calx-beta; 1.
DR   Pfam; PF19309; Frem_N; 1.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF141072; SSF141072; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
DR   PROSITE; PS51854; CSPG; 12.
PE   1: Evidence at protein level;
KW   Alternative splicing; Basement membrane; Calcium; Cell adhesion;
KW   Developmental protein; Disulfide bond; Extracellular matrix; Glycoprotein;
KW   Lectin; Metal-binding; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..29
FT                   /evidence="ECO:0000255"
FT   CHAIN           30..2191
FT                   /note="FRAS1-related extracellular matrix protein 1"
FT                   /id="PRO_0000010123"
FT   REPEAT          300..394
FT                   /note="CSPG 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   REPEAT          419..506
FT                   /note="CSPG 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   REPEAT          527..621
FT                   /note="CSPG 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   REPEAT          648..779
FT                   /note="CSPG 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   REPEAT          801..892
FT                   /note="CSPG 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   REPEAT          912..1007
FT                   /note="CSPG 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   REPEAT          1049..1151
FT                   /note="CSPG 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   REPEAT          1172..1273
FT                   /note="CSPG 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   REPEAT          1294..1391
FT                   /note="CSPG 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   REPEAT          1412..1504
FT                   /note="CSPG 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   REPEAT          1525..1614
FT                   /note="CSPG 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   REPEAT          1650..1742
FT                   /note="CSPG 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01201"
FT   DOMAIN          1749..1848
FT                   /note="Calx-beta"
FT   DOMAIN          2072..2186
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   REGION          1874..1921
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           205..207
FT                   /note="Cell attachment site"
FT   COMPBIAS        1896..1912
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        341
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        566
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        628
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1039
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1180
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1584
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        2163..2177
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   VAR_SEQ         729..747
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15878328"
FT                   /id="VSP_015032"
FT   VAR_SEQ         1500..1544
FT                   /note="RFTISNGLQTQRGVFEITLQTVDSALPVLTKNKRLRLAEGAMGLL -> SRW
FT                   GHKSPCRLPCLSLPDLPSAMDCRPSVGCLKSHCRLWTAPCLC (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_015033"
FT   VAR_SEQ         1545..2191
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_015034"
FT   MUTAGEN         207
FT                   /note="D->E: Impairs cell adhesion ability in vitro."
FT                   /evidence="ECO:0000269|PubMed:15878328"
SQ   SEQUENCE   2191 AA;  244544 MW;  A7D18FD3E32FD3C3 CRC64;
     MHSPGCTGPK AQWFLLLQLL LLHLDRVSAT FISINRGLRV MKGSSAFLSG DHLRVAVPKE
     KDACRLEVVM NEPVTQRVGK LSPQVFDCHF LPNEVKYVHN GCPILDEDSV KLRLYRFTET
     DTFMETFLLR VYLVEPDCNI IRMSSNVLEV TEFYGLSQAI DKNLLQFDYD RTASLDCTIR
     LDPLRTQLPA HGKLVVVNRK SEGPRGDQPH SFFSETELGA GLKCPDGSCA LELKQVASLK
     VSCEEFLLTG FHYQHMQPPS PNIDYIPIQL DLTDRRSKTV YKSESAWLPV YIRVGIPNQV
     PRAAFMAMFV LEVDQFILTP LTTSVLDCEE DETPKPLLVF NITKAPLQGY VTHLLDHTRP
     ISSFTWKDLS DMQVAYQPPN SSHPERRHYT MELEVYDFFF ERSAPITVHI SIRTADTNAP
     RVSWNTGLNL LEGQSRAITW EQFQIVDNDD IGAVQLVTIG GLQHGRLTVR EGKGFLFTVT
     DLQAGVVRYH HDDSDTTKDF VAFRIFDGHH SSHHKFPINI LPKDDSPPFL ITNVVIELEE
     GKTILIQGSM LRASDMDSSD DYIFFNITKF PQAGEIMKKP GPRLIGYPVP GFLQRDLFSG
     IIYYRHFGGE IFEDSFEFVL WDSHEPPNLS VPQVVTIHIT PVDDQLPKEA PGISRHLVVK
     ETEVAYITKK HLHFLDMESR DGELIYTVTR PPCFSFSHRH LDAGKLFMVD SIPKLTKNPT
     APGLSSFTQG LILISANQHT CSSQFASQHA VNHMKVAYMP PMQDIGPSPR HVQFTVSVSN
     QHGGALHGIC FNITVLPVDN QVPEVFTNTL RVVEGGQCTI STEHILVSDV DTPLDSISLS
     LKERPLHGGV ELDGFPLNPR GTFSWRDLNT LKVWYQHDGS EVLQDEIFLE VTDGTNSAAF
     VLHIEVFPVN DEPPILKADL IPMMHCSEGG EVTITPEYIS ATDADSDDLE LLFLIAREPQ
     HGVVRKAGLH VDRFSQGDVI SGAVTYKHTG GEIGLEPCSD TVVLVVSDGE ADPLMNGCCY
     DGPDSSVPLH KSFPTYQLNI TVHPVDNQPP SIIIGRMLTV DEGFSAALTT HHLTVVDWDT
     APDDLKFMLA SQPQFGYLEN ALPSAGFEKS NIGIRIASFQ WTDMKASHIN YVQSRHLRVE
     PTADQFTVYA TDGKHRSLET TFHVIINPTN DEAPDLAVQN ITVYEGHMVE LDSSIISATD
     RDIPKDPLLF SIALKPQHGL LVDAAISKDS HQIKQLQHEI HSFSVDLLKN GMKLVYAHDD
     SESSADNFVI QLSDGKHKIL KTISVNITPV NDETPTLSKK AEISMAVGDT RVLSSAVLSA
     TDKDSPREKI HYVFERLPQN GQLQLKIGRD WVPLSTGMQC TQEDVDLNLL RYTHAGKTDS
     QDGDSFTFYL WDEDNRSPAF DCHIIIEDMG KGDIVIHAKP LVVVKGDRGL LTTATLLAVD
     GADKPEELLY LITSPPRHGQ VEYVHSPGVP IASFSQMDIA GQTVCYIHKS RTAVPTDSFR
     FTISNGLQTQ RGVFEITLQT VDSALPVLTK NKRLRLAEGA MGLLSADHLQ LTDPDTPPEN
     LTFFLAQLPR HGYLFLRGKA LQHNFTQRDV DSGGVAYQHS GGGAREDYFT FLATDRKNQG
     FVVDGKVQKE PVRFTIQVDQ LDKAAPRITH LHSPTQVGLL KNGCYGIYIT SRVLKASDPD
     TEDDQIIFKI LRGPLYGRLE NTTTGEFIHE RFSQKDLSHK TILYIINPSL QVTSDILEFQ
     AMDPTGNTAT PQSLDLRWSY IEWAQTAYEV CENVGLLPLE VTRRGYPMDS AFVGVEVNQV
     SATVGKDFTV TPSKLLQFDP GMSTKMWNIA ITYDGLEEDD EVFEVILNSP VNAVLGTQTK
     AAVKILDSKG GRCHPSNSFN QSKHSTWGKG PWHPLPSGSS SLTTSGSPLL ERPPPSFTSG
     DALQGFGLTD LTQRKTMTQG NGKSVLPSSV CRNGTDTIYN YHGIVSLKLE GDRFSAHKRK
     AKISIVSQPQ RTIKVAELPL ADKVESTTDL HFLRQGLRPL FPKNCSVDLK GLFHFEESTH
     RLYQCDGISW KAWSPQTKGL EDRSCPGGWL LHSGYCHILV TRQKGTWTTA TRACREQHQG
     DLVTVLSRRH MQWLWAMSGR KPFWIGLKNQ PRTGHWEWIG GEPVAFTNWR RGAPLHPKPG
     KNCALVQKRG QWQTKNCSKG KAHNFVCSRK L
//
